Condition: Coronary Artery Disease · Sponsor: Teleflex
The purpose of the study is to assess the safety and efficacy of the Orsiro® Mission 48- mm Sirolimus-Eluting Coronary Stent System in the treatment of subjects with atherosclerotic lesion(s) \>36 mm and ≤ 44 mm in length (by visual estimate) in the native coronary arteries with a reference vessel diameter of 2.25 mm to 4.0 mm. Patients enrolled in the United States will be followed for 2 years post index procedure with follow-up visits at 1, 6, 12 months and 2 years post index procedure. Patients enrolled outside of the United States will be followed through 5 years post index procedure with additional follow-up visits at 3 and 5 years post index procedure.
This description comes directly from the study's public registry record.
BIOFLOW-48 Project Manager · 1-866-246-6990 · bioflow-48@teleflex.com
Always discuss trial participation with your own doctor first.
| John Muir Medical Center | Concord, California, United States | Recruiting |
| Ascension Via Christi Hospitals Wichita | Wichita, Kansas, United States | Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
| Henry Ford Hospital | Detroit, Michigan, United States | Recruiting |
| Barnes Jewish Hospital | St Louis, Missouri, United States | Recruiting |
| North Shore University Hospital | Manhasset, New York, United States | Recruiting |
| Columbia University Irving Medical Center/New York Presbyterian Hospital | New York, New York, United States | Recruiting |
| Baylor Scott & White The Heart Hospital - Dallas | Dallas, Texas, United States | Recruiting |
| Ascension Texas Cardiovascular | Kyle, Texas, United States | Recruiting |
| Charleston Area Medical Center | Charleston, West Virginia, United States | Recruiting |
| Universitätsklinik für Innere Medizin II, Klinische Abteilung für Kardiologie, Medizinische Universität Wien | Vienna, State of Vienna, Austria | Active Not Recruiting |
| Klinische Abteilung für Kardiologie, Medizinische Universität Graz | Graz, Styria, Austria | Active Not Recruiting |
+ 11 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06779630